Abstract
The article presents the findings of the research on the antagonistic properties of lactobacillus strains against conditionally pathogenic clinical isolates that cause intestinal inflammation. Conditionally pathogenic clinical isolates of colon (large intestine) and rectum (straight intestine) were isolated and identified to the described species level. From a variety of dairy products, 28 milk-fermenting lactobacilli were isolated, screened, and their probiotic probiotic properties were studied. From 28 isolates of isolated milk-fermenting bacteria, 7 strains were selected. The selected strains showed high antimicrobial activity against clinical and typical conditional pathogenic isolates causing intestinal inflammatory diseases (ulcerative colitis). For this reason, these strains can be recommended as a means of treatment and prevention of intestinal infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Frontline Medical Sciences and Pharmaceutical Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
